Clinical Trial

Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate whether Insulex® R demonstrates similar pharmacokinetic (PK) and pharmacodynamic (PD) profiles compared to Humulin® R after a single subcutaneous dose of 0.3 units/kg in healthy adult volunteers.
Trial Details
NCT Number NCT07364669
Lead Sponsor Laboratorios Pisa S.A. de C.V.
Collaborators: ProSciento, Inc.
Conditions Healthy Subjects
Enrollment 40 participants
Start Date 2024-10-24
Primary Completion 2025-02-01 (estimated)
Study Completion 2025-05-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-23